Dr. Reddys Laboratories Ltd.

BSE: 500124 | NSE: DRREDDY
Large Cap | Pharmaceuticals & Drugs
1175.55
-10.90 (-0.92%)
< Home < Back

Dr Reddy's Laboratories eyeing to enhance presence in emerging segments like nutraceuticals

Date: 11-07-2023

Dr Reddy's Laboratories is eyeing to enhance its presence in various emerging segments like nutraceuticals and aims to get into integrated digital healthcare services as part of its future growth plans.

It is exploring business spaces that will shape the healthcare of the future. These include deepening its presence in nutraceuticals, cell and gene therapy and new chemical entities (NCEs). The drug firm is also exploring new spaces such as integrated digital healthcare services, digital therapeutics, and disease management. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.